Despite an increasing amount of research on biomedical named entity recognition, there has been not enough work done on disease mention recognition. Difficulty of obtaining adequate corpora is one of the key reasons which hindered this particular research. Previous studies argue that correct identification of disease mentions is the key issue for further improvement of the disease-centric knowledge extraction tasks. In this paper, we present a machine learning based approach that uses a feature set tailored for disease mention recognition and outperforms the state-ofthe-art results. The paper also discusses why a feature set for the well studied gene/protein mention recognition task is not necessarily equally effective for other biomedical semantic types such as diseases.
Introduction
The massive growth of biomedical literature volume has made the development of biomedical text mining solutions indispensable. One of the essential requirements for a text mining application is the ability to identify relevant entities, i.e. named entity recognition. Previous work on biomedical named entity recognition (BNER) has been mostly focused on gene/protein mention recognition. Machine learning (ML) based approaches for gene/protein mention recognition have already achieved a sufficient level of maturity (Torii et al., 2009) . However, the lack of availability of adequately annotated corpora has hindered the progress of BNER research for other semantic types such as diseases (Jimeno et al., 2008; Leaman et al., 2009) .
Correct identification of diseases is crucial for various disease-centric knowledge extraction tasks (e.g. drug discovery (Agarwal and Searls, 2008) ). Previous studies argue that the most promising candidate for the improvement of disease related relation extraction (e.g. disease-gene) is the correct identification of concept mentions including diseases (Bundschus et al., 2008) .
In this paper, we present a BNER system which uses a feature set specifically tailored for disease mention recognition. The system 1 outperforms other approaches evaluated on the Arizona Disease Corpus (AZDC) (more details in Section 5.1). One of the key differences between our approach and previous approaches is that we put more emphasis on the contextual features. We exploit syntactic dependency relations as well. Apart from the experimental results, we also discuss why the choice of effective features for recognition of disease mentions is different from that for the well studied gene/protein mentions.
The remaining of the paper is organized as follows. Section 2 presents a brief description of previous work on BNER for disease mention recognition. Then, Section 3 describes our system and Section 4 the feature set of the system. After that, Section 5 explains the experimental data, results and analyses. Section 6 describes the differences for the choice of feature set between diseases and genes/proteins. Finally, Section 7 concludes the paper with an outline of our future research.
Related Work
Named entity recognition (NER) is the task of locating boundaries of the entity mentions in a text and tagging them with their corresponding semantic types (e.g. person, location, gene and so on). Although several disease annotated corpora have been released in the last few years, they have been annotated primarily to serve the purpose of relation extraction and, for different reasons, they are not suitable for the development of ML based disease mention recognition systems (Leaman et al., 2009) . For example, the BioText (Rosario and Hearst, 2004) corpus has no specific annotation guideline and contains several inconsistencies, while PennBioIE (Kulick et al., 2004) is very specific to a particular sub-domain of diseases. Among other disease annotated corpora, EBI disease corpus (Jimeno et al., 2008) is not annotated with disease mention boundaries which makes it unsuitable for BNER evaluation for diseases. Recently, an annotated corpus, named as Arizona Disease Corpus (AZDC) (Leaman et al., 2009) , has been released which has adequate and suitable annotation of disease mentions following specific annotation guidelines.
There has been some work on identifying diseases in clinical texts, especially in the context of CMC Medical NLP Challenge 2 and i2b2 Challenge 3 . However, as noted by Meystre et al. (2008) , there are a number of reasons that make clinical texts different from texts of biomedical literature, e.g. composition of short, telegraphic phrases, use of implicit templates and pseudotables and so on. Hence, the strategies adopted for NER on clinical texts are not the same as the ones practiced for NER on biomedical literature.
As mentioned before, most of the work to date on BNER is focused on gene/protein mention recognition. State-of-the-art BNER systems are based on ML techniques such as conditional random fields (CRFs), support vector machines (SVMs) etc (Dai et al., 2009 ). These systems use either gene/protein specific features (e.g. Greek alphabet matching) or post-processing rules (e.g. extension of the identified mention boundaries to the left when a single letter with a hyphen precedes them (Torii et al., 2009 )) which might not be as effective for other semantic type identification as they are for genes/proteins. There is a substantial agreement in the feature set that these systems use (most of which are actually various orthographical and morphological features). Bundschus et al. (2008) have used a CRF based approach that uses typical features for gene/protein mention recognition (i.e. no feature tailoring for disease recognition) for disease, gene and treatement recognition. The work has been evaluated on two corpora which have been anno-tated with those entities that participate in diseasegene and disease-treatment relations. The reported results show F-measure for recognition of all the entities that participate in the relations and do not indicate which F-measure has been achieved specifically for disease recognition. Hence, the reported results are not applicable for comparison.
To the best of our knowledge, the only systematic experimental results reported for disease mention recognition in biomedical literature using ML based approaches are published by Leaman and Gonzalez (2008) and Leaman et al. (2009) . 4 They have used a CRF based BNER system named BANNER which basically uses a set of orthographic, morphological and shallow syntactic features (Leaman and Gonzalez, 2008) . The system achieves an F-score of 86.43 on the BioCreative II GM corpus 5 which is one of the best results for gene mention recognition task on that corpus.
BANNER achieves an F-score of 54.84 for disease mention recognition on the BioText corpus (Leaman and Gonzalez, 2008) . However, as said above, the BioText corpus contains annotation inconsistencies 6 . So, the corpus is not ideal for comparing system performances. The AZDC corpus is much more suitable as it is annotated specifically for benchmarking of disease mention recognition systems. An improved version of BAN-NER achieves an F-score of 77.9 on AZDC corpus, which is the state of the art on ML based disease mention recognition in biomedical literature (Leaman et al., 2009 ).
Description of Our System
There are basically three stages in our approachpre-processing, feature extraction and model training, and post-processing.
Pre-processing
At first, the system uses GeniaTagger 7 to tokenize texts and provide PoS tagging. After that, it corrects some common inconsistencies introduced by GeniaTagger inside the tokenized data (e.g. GeniaTagger replaces double inverted commas with two single inverted commas). These PoS tagged tokized data are parsed using Stanford parser 8 . The dependency relations provided as output by the parser are used later as features. The tokens are further processed using the following generalization and normalization steps:
• each number (both integer and real) inside a token is replaced with '9'
• each token is further tokenized if it contains either punctuation characters or both digits and alphabetic characters
• all letters are changed to lower case
• all Greek letters (e.g. alpha) are replaced with G and Roman numbers (e.g. iv) with R
• each token is normalized using SPECIALIST lexicon tool 9 to avoid spelling variations
Feature extraction and model training
The features used by our system can be categorized into the following groups:
• general linguistic features (Table 1) • orthographic features (Table 2) • contextual features (Table 3) • syntactic dependency features (Table 4) • dictionary lookup features (see Section 4)
During dictionary lookup feature extraction, we ignored punctuation characters while matching dictionary entries inside sentences. If a sequence of tokens in a sentence matches an entry in the dictionary, the leftmost token of that sequence is labeled with B-DB and the remaining tokens of the sequence are labeled with I-DB. The label B-DB indicates the beginning of a dictionary match. If a token belongs to several dictionary matches, then all the other dictionary matches except the longest one are discarded.
The syntactic dependency features are extracted from the output of the parser while the general linguistic features are extracted directly from the preprocessed tokens. To collect the orthographic features, the original tokens inside the corresponding sentences are considered. The contextual features are derived using other extracted features and the original tokens.
Tokens are labeled with the corresponding disease annotations according to the IOB2 format. Our system uses Mallet (McCallum, 2002) to train a first-order CRF model. CRF is a state-of-theart ML technique applied to a variety of text processing tasks including named entity recognition (Klinger and Tomanek, 2007) and has been successfully used by many other BNER systems (Smith et al., 2008) .
Post-processing
Once the disease mentions are identified using the learned model, the following post-processing techniques are applied to reduce the number of wrong identifications:
• Bracket mismatch correction: If there is a mismatch of brackets in the identified mention, then the immediate following (or preceding) character of the corresponding mention is checked and included inside the mention if that character is the missing bracket. Otherwise, all the characters from the index where the mismatched bracket exists inside the identified mention are discarded from the corresponding mention.
• One sense per discourse: If any instance of a character sequence is identified as a disease mention, then all the other instances of that character sequence inside the same sentence are also annotated as disease mentions.
• Short/long form annotation: Using the algorithm of Schwartz and Hearst (2003) , "long form (short form)" instances are detected inside sentences. If the short form is annotated as disease mention, then the long form is also annotated and vice versa.
• Ungrammatical conjunction structure correction: If an annotated mention contains comma (,) but there is no "and" in the following character sequence (from the character index of that comma) of that mention, then the annotation is splitted into two parts (at the index of the comma). Annotation of the original mention is removed and the splitted parts are annotated as two separate disease mentions.
• Short and long form separation: If both short and long forms are annotated in the same mention, then the original mention is discarded and the corresponding short and long forms are annotated separately.
Features for Disease Recognition
There are compelling reasons to believe that various issues regarding the well studied gene/protein mention recognition would not apply to the other semantic types. For example, Jimeno et al. (2008) argue that the use of disease terms in biomedical literature is well standardized, which is quite opposite for the gene terms (Smith et al., 2008) . After a thorough study and extensive experiments on various features and their possible combinations, we have selected a feature set specific to the disease mention identification which comprises features shown in Tables 1, 2, 4 and 3, and dictionary lookup features. Bi-grams of for i − 2 ≤ k < i + 2 normalized tokens Tri-gram k,k+1,k+2
Tri-grams of for i − 2 ≤ k < i + 2 normalized tokens CtxPoS k,k+1
Bi-grams of for i ≤ k < i + 2 token PoS CtxLemma k,k+1
Bi-grams of for i ≤ k < i + 2 lemmatized tokens CtxWord k,k+1
Bi-grams of for i − 2 ≤ k < i + 2 original tokens Offset conjunctions
Extracted by Mallet from features in the range from token i−1 to token i+1 For example, in the sentence "Clinton defeated Dole", "Clinton" is the nsubj of the target token "defeated". the semantic group "DISORDER" 10 from UMLS Metathesaurus (Bodenreider, 2004) : (i) disease or syndrome, (ii) neoplastic process, (iii) congenital abnormality, (iv) acquired abnormality, (v) experimental model of disease, (vi) injury or poisoning, (vii) mental or behavioral dysfunction, (viii) pathological function and (ix) sign or symptom.
We have not considered the other three semantic types (findings, anatomical abnormality and cell or molecular Dysfunction) since these three types have not been used during the annotation of Arizona Disease Corpus (AZDC) which we have used in our experiments. Previous studies have shown that dictionary lookup features, i.e. name matching against a dictionary of terms, often increase recall (Torii et al., 2009; Leaman et al., 2009 ). However, an unprocessed dictionary usually does not boost overall performance (Zweigenbaum et al., 2007) . So, to reduce uninformative lexical differences or spelling variations, we generalize and normalize the dictionary entries using exactly the same steps followed for the pre-processing of sentences (see Section 3.1).
To reduce chances of false and unlikely matches, any entry inside the dictionary having less than 3 characters or more than 10 tokens is discarded.
Experiments

Data
We have done experiments on the recently released Arizona Disease Corpus (AZDC) 11 (Leaman et al., 2009) . The corpus has detailed annotations of diseases including UMLS codes, UMLS concept names, possible alternative codes, and start and end points of disease mentions inside the corresponding sentences. These detailed annotations make this corpus a valuable resource for evaluating and benchmarking text mining solutions for disease recognition. For the overlapping annotations, (e.g. "endometrial and ovarian cancers" and "ovarian cancers") we have considered only the larger annotations in our experiments. There remain 3,224 disease mentions after resolving overlaps according to the aforementioned criterion. We have observed minor differences in some statistics of the AZDC reported by Leaman et al. (2009) with the statistics of the downloadable version 12 (Table 5) . How-11 Downloaded from http://diego.asu.edu/downloads/AZDC/ at 5-Feb-2009 12 Note that "Disease mentions (total)" in the paper of Leaman et al. (2009) actually refers to the total disease mentions after overlap resolving (Robert Leaman, personal communication) . One other thing is, Leaman et al. (2009) mention 794 ever, these differences can be considered negligible.
Results
We follow an experimental setting similar to the one in Leaman et al. (2009) so that we can compare our results with that of the BANNER system. We performed 10-fold cross validation on AZDC in such a way that all sentences of the same abstract are included in the same fold. The results of all folds are averaged to obtain the final outcome. Table 6 shows the results of the experiments with different features using the exact matching criterion.
As we can see, our approach achieves significantly higher result than that of BANNER. Initially, with only the general linguistic and orthographic features the performance is not high. However, once the contextual features are used, there is a substantial improvement in the result. Note that BANNER does not use contextual features. In fact, the use of contextual features is also quite limited in other BNER systems that achieve high performance for gene/protein identification (Smith et al., 2008) .
Dictionary lookup features provide a very good contribution in the outcome. This supports the argument of Jimeno et al. (2008) that the use of disease terms in biomedical literature is well standardized. Post-processing and syntactic dependency features also increase some performance.
We have done statistical significance tests for the last four experimental results shown in Table 6 . For each of such four experiments, the immediate previous experiment is considered as the baseline. The tests have been performed using the approximate randomization procedure (Noreen, 1989) . We have set the number of iterations to 1,000 and the confidence level to 0.01. According to the tests, the contributions of contextual features and dictionary lookup features are statistically significant. However, we have found that the contributions of post-processing rules and syntactic dependency features are statistically significant only when the confidence level is 0.2 or more. Since AZDC consists of only 2,783 sentences, we can assume that the impact of post-processing rules abstracts, 2,784 sentences and 3,228 (overlap resolved) disease mentions in the AZDC. But in our downloaded version of AZDC, there is 1 abstract missing (i.e. total 793 abstracts instead of 794). As a result, there is 1 less sentence and 4 less (overlap resolved) disease mentions than the originally reported numbers. and syntactic dependency features has been not so significant despite of some performance improvement.
Error analysis
One of the sources of errors is the annotations having conjunction structures. There are 94 disease mentions in the data which contain the word "and". The boundaries of 11 of them have been wrongly identified during experiments, while 39 of them have been totally missed out by our system. Our system also has not performed well for disease annotations that have some specific types of prepositional phrase structures. For example, there are 80 disease annotations having the word "of" (e.g. "deficient activity of acid betaglucosidase GBA"). Only 28 of them are correctly annotated by our system. The major source of errors, however, concerns abbreviated disease names (e.g. "PNH"). We believe one way to reduce this specific error type is to generate a list of possible abbreviated disease names from the long forms of disease names available in databases such as UMLS Metathesaurus.
Why Features for Diseases and
Genes/Proteins are not the Same
Many of the existing BNER systems, which are mainly tuned for gene/protein identification, use features such as token shape (also known as word class and brief word class (Settles, 2004) ), Greek alphabet matching, Roman number matching and so forth. As mentioned earlier, we have done extensive experiments with various feature combinations for the selection of disease specific features. We have observed that many of the features used for gene/protein identification are not equally effective for disease identification. Table 7 shows some of the results of those experiments. This observation is reasonable because gene/protein names are much more complex than entities such as diseases. For example, they often contain punctuation characters (such as parentheses or hyphen), Greek alphabets and digits which are unlikely in disease names. Ideally, the ML algorithm itself should be able to utilize information from only the useful features and ignore the others in the feature set. But practically, having non-informative features often mislead the model learning. In fact, several surveys have argued that the choice of features matter at least as much as the choice of the algorithm if not more (Nadeau and Sekine, 2007; Zweigenbaum et al., 2007) .
One of the interesting trends in gene/protein mention identification is to not utilize syntactic dependency relations (with the exception of Vlachos (2007) ). Gene/protein names in biomedical literature are often combined (i.e. without being separated by space characters) with other characters which do not belong to the corresponding mentions (e.g. p53-mediated). Moreover, as mentioned before, gene/protein mentions commonly have very complex structures (e.g. PKR(1-551)K64E/K296R or RXRalphaF318A). So, it is a common practice to tokenize gene/proten names adopting an approach that split tokens as much as possible to extract effective features (Torii et al., 2009; Smith et al., 2008) . But while the extensive tokenization boosts performance, it is often difficult to correctly detect dependency relations for the tokens of the gene/protein names in the sentences where they appear. As a result, use of the syntactic dependency relations is not beneficial in such approaches. 13 In comparison, disease mentions are less complex. So, the identified dependencies for disease mentions are more reliable and hence may be usable as potential features (refer to our experimental results in Table 6 ).
The above mentioned issues are some of the reasons why a feature set for the well studied gene/protein focused BNER approaches is not necessarily suitable for other biomedical semantic types such as diseases.
Conclusion
In this paper, we have presented a single CRF classifier based BNER approach for disease mention identification. The feature set is constructed using disease-specific contextual, orthographic, general linguistic, syntactic dependency and dictionary lookup features. We have evaluated our approach on AZDC corpus. Our approach achieves significantly higher result than BANNER which is the current state-of-the-art ML based approach for disease mention recognition. We have also explained why the choice of features for the well studied gene/protein does not apply for other semantic types such as diseases.
System
Note Precision Recall F-score BANNER (Leaman et al., 2009) Table 7 : Experimental results of our system after using some of the gene/protein specific features for disease mention recognition on AZDC. Here, WC and BWC refer to the "word class" and "brief word class" respectively.
Future work includes implementation of disease mention normalization (i.e. associating a unique identifier for each disease mention). We also plan to improve our current approach by including more contextual features and post-processing rules.
